These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Selmaj I; Cichalewska M; Namiecinska M; Galazka G; Horzelski W; Selmaj KW; Mycko MP Ann Neurol; 2017 May; 81(5):703-717. PubMed ID: 28411393 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis. Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949 [TBL] [Abstract][Full Text] [Related]
9. Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis. Mohamed MS; Nahrery EMAE; Shalaby N; Hussein M; Aal RAE; Mohamed MM Mult Scler Relat Disord; 2019 Feb; 28():226-229. PubMed ID: 30623862 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Selected MicroRNAs Expression in Remission Phase of Multiple Sclerosis and Their Potential Link to Cognition, Depression, and Disability. Niwald M; Migdalska-Sęk M; Brzeziańska-Lasota E; Miller E J Mol Neurosci; 2017 Dec; 63(3-4):275-282. PubMed ID: 29043654 [TBL] [Abstract][Full Text] [Related]
11. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898 [TBL] [Abstract][Full Text] [Related]
12. Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures. Dolcino M; Pelosi A; Fiore PF; Patuzzo G; Tinazzi E; Lunardi C; Puccetti A Front Immunol; 2018; 9():449. PubMed ID: 29559981 [TBL] [Abstract][Full Text] [Related]
13. miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease. Torabi S; Tamaddon M; Asadolahi M; Shokri G; Tavakoli R; Tasharrofi N; Rezaei R; Tavakolpour V; Sazegar H; Kouhkan F Immunogenetics; 2019 Feb; 71(2):87-95. PubMed ID: 30310937 [TBL] [Abstract][Full Text] [Related]